The Roles of microRNA in Tumor Initiation and Development: Diagnostic and Therapeutic Potential
A special issue of Cancers (ISSN 2072-6694).
Deadline for manuscript submissions: closed (30 April 2017) | Viewed by 61726
Special Issue Editors
Interests: cancer biology; small rna; intra- and extracellular communication; animal models of human disease; translational research
Special Issues, Collections and Topics in MDPI journals
Interests: cancer biology; small RNA; cancer stem cells; drug resistance; translational research
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
MicroRNA (miRNA) is one of the non-coding RNAs that plays important roles in gene regulation, mainly at the post-transcriptional level, and compromises a large family of approximately 20–22 small nucleotide. A number of studies have reported that miRNAs support the maintenance of biological homeostasis, and that aberrant expression of miRNAs are associated with the onset of many diseases, including cancer. This Special Issue of Cancers will firstly introduce the role of miRNAs in tumor development, and will then review their therapeutic potential for cancer therapy. The next several articles will focus on the secreted miRNAs that are packaged into the small endosome-derived vesicles called exosomes, generated from the multiple cell types, including immunocytes and cancer cells. Because secreted miRNAs also play an important role in cell-to-cell communication, they have been investigated as prognostic and diagnostic biomarkers.
Dr. Takahiro Ochiya
Dr. Ryou-u Takahashi
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- MicroRNA
- Tumor development
- Therapeutic approach
- Circulating microRNA
- Exosomal microRNA
- Prognostic and diagnostic markers